Erik van Ginkel, M.D.
hippocrates

true to the hippocratic oath Dr van Ginkel tries to:

first; do no harm

second: try to alleviate pain and suffering

About Dr van Ginkel

 

 

Erik van Ginkel, M.D.

                                                               Board Certified in Family Practice

                                                 Addiction Medicine – Medical Management of Pain

 

PERSONAL

 

Erik van Ginkel, M.D.Miami, Florida  33143

Date of Birth: March 27, 1952

Place of Birth: Holland

 

OFFICE

 

Erik van Ginkel, M.D.

7000 sw 62 av suite 400

Tel; 305 665 0585

e-mail: md@miamipainandrecovery.com

Website:miamipainandrecovery.com

South Miami Clinical Research, LLC

7000 S.W. 62nd Avenue, Suite 402

South Miami, Florida 33143

 

EMPLOYMENT

 

 

1988 – 2000         Private Practice in Family Medicine, Miami,  Florida    

 

1991– 1993         Assistant Director , South Miami Hospital

                            Addiction Treatment Program

 

1992– 2007         Director, South Miami Hospital

                            Addiction Treatment Program

 

     2008 – Present   Private Practice in Family Medicine

                 Pain Management and Addictive Disease

 

 

 

July 2012 Program Director of the Addiction Fellowship at Larkin

 

 

 

EDUCATION

 

1985– 1988        Residency in Family Practice, University of TexasHouston, Texas

 

    1983 - 1985        Fellowship in Surgical Nutrition- Saint Luke’s Episcopal Hospital

                                Houston, Texas

 

1981 – 1983        Fellowship in General Surgical – Amsterdam, The Netherlands

 

    1973 – 1981        Medical School, Free University of Amsterdam-Amsterdam,

                           The Netherlands

2013-present     Assistant professor dept of Family Medicine at NOVA University

                                

PROFESSIONAL MEMBERSHIP

 

AMA, American Society of Addiction Medicine, American Pain Society

 

CERTIFICATIONS/LICENSES

 

Licensed MRO 2009

Board Certified in Family Practice 1988 – 2012

Medical Licensure in the State of Florida 1988 – 2009

American Society of Addiction Medicine  1995

Educational Council for Foreign Medicine Graduates

Licensed to Practice Medicine in the Netherlands  1981

 

LANGUAGES

 

English, Dutch, French, and German – Fluent

Spanish - basic

 

             CLINICAL RESEARCH EXPERIENCE

 

                2006-2007         Phase III, HIV

             

                2006-2006         Phase III, Mild Hypertension    

 

2006-2006         Phase III, Hyperlipdemia

 

2005-2006         Phase II, Hypercholesterolemia

 

2005-2005         Phase IIIB, Gout

 

2005-2005         Phase III, Mild to Moderate Asthma

              

2005-2005         Phase III, COPD

 

Avexa Ltd-Protocol No. AVX-301 Phase 2b/3 HIV-1 Infected Patients

February 2008 – 2009

 

Novartis Pharmaceuticals-Protocol No. CQAB149B2335S / Extension Phase II/III COPD

August 2007 – April 2009

 

Novartis Pharmaceuticals-Protocol No. CNVA237A2206  Phase II COPD

September 2007 - February 2008

 

Tap Pharmaceuitcals Products, Inc.-Protocol No. F-GT06-153 Phase III Gout

March 2007 - May 2008

 

Novartis Pharmaceuticals-Protocol No. CQAB149B2338 Phase III Asthma

March 2008 - October 2008

 

Novartis Pharmaceuticals-Protocol No. CQAB149B2346 Phase III COPD

February 2008 - September 2008   

 

GlaxoSmithKline-Protocol N0. ADC111891 Phase IV COPD

November 2008 – June 2009

 

Novartis Pharmaceuticals-Protocol No. CQAB149B2349 Phase IIIB  COPD

February 2009 - Present  

 

Novartis Pharmaceuticals-Protocol No. CIGE025AUS33 Phase IV  Asthma

February 2009 - Present   

 

 

 

CLINICAL RESEARCH EXPERIENCE

 

Novartis Pharmaceuticals-Protocol No. CSPV100AU01 Phase IV  Hypertension

February 2009 - Present   

 

GlaxoSmithKline-Protocol N0. PXN110527 Phase IIa Neuropathic Pain

February 2009 – Present

 

 

Speakers bureau

 

Purdue

Pfizer

Reckitt Benckiser

Endo

King

 

 

CO-HOST ON RADIO PROGRAM; reality radio

880 AM “the biz” wednesday NIGHTS FROM 9-11 PM